Search studies

57 studies found

APPROACH source cohorts
dc9a475c-147a-11eb-b51f-8c8590c45a21

All baseline cohort parameters, clinical, conventional (knee x-ray and MRI and the robust biochemical markers), and novel markers (T2 relaxation MRI for cartilage collagen distribution, gagCEST MRI cartilage for proteoglycan content, knee CT/x-ray for bone shape and trabecular architecture, knee motion, and novel biochemical markers describing turnover of specific tissue component, as well as involvement of hand, hip and spine joint damage, hand joint inflammation, hip motion and shape and bo...

BI Immuno-stimulant study
ELU-4-61FD55-1

BI Immuno-stimulant study

BIOMAP
b70ca060-813e-11ed-9414-acde48001122

fairplus stamp

Aggregation of all BIOMAP cohorts

CARE
532cda6a-ee0a-11eb-920d-acde48001122

fairplus stamp

Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity

DIRECT
dc9ae590-147a-11eb-b51f-8c8590c45a21

Interim analysis. Study outline is available in Diabetologia (2014) 57:1132–1142.

EBiSC study
ef8de6f2-51c4-11eb-89dd-acde48001122

fairplus stamp

The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality tools for new medicines development.

EBiSC2 study
670afece-2432-11eb-8464-acde48001122

fairplus stamp

The European Bank for induced pluripotent Stem Cells (EBiSC) is a centralised, not-for-profit iPSC bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality tools for new medicines development.

EPAD
dc9ad7c6-147a-11eb-b51f-8c8590c45a21

Observational Study. More details available at http://datacat.uni.lu/additional_files/EPAD_Study_Protocol_Description.htm